Pegylated dendrimer and its effect in fluorouracil loading and release for enhancing antitumor activity

Journal of Biomedical Nanotechnology

Volumn 9, Issue 2, 2013, Pages 213-220

  Ly, Tu Uyen ^a   Tran, Ngoc Quyen ^a   Hoang, Thi Kim Dung ^a   Phan, Kim Ngoc ^b   Truong, Hai Nhung ^b   Nguyen, Cuu Khoa ^a  

^a GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

^b UNIVERSITY OF NATURAL SCIENCES   (Viet Nam)

Author keywords

Anticancer; Drug Delivery; Fluorouracil; Pegylated Dendrimer

Indexed keywords

ANTI-CANCER DRUG DELIVERY; ANTI-PROLIFERATIVE ACTIVITIES; ANTI-TUMOR ACTIVITIES; ANTICANCER; BIOMEDICAL APPLICATIONS; FLUOROURACIL; HYPERBRANCHED POLYMERS; PEGYLATED;

CELL CULTURE; DENDRIMERS; DIAGNOSIS; DRUG DELIVERY; LOADING; MEDICAL APPLICATIONS; TUMORS;

FUNCTIONAL POLYMERS;

DENDRIMER; FLUOROURACIL; POLYAMIDOAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER SIZE; CELL DENSITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CHROMATOGRAPHY, GEL; DENDRIMERS; FLUOROURACIL; HLA-DR ANTIGENS; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MCF-7 CELLS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; POLYETHYLENE GLYCOLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84876512877     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1479     Document Type: Article

References (24)

1. D. A. Tomalia, H. Baker, J. Dewald, M. Hall, G. Kallos, S. Martin, J. Roeck, J. Ryder, and P. Smith, A new class of polymers: starburstdendritic macromolecules. Polym. J. 17, 117 (1985).
2. E. Malmstroem, M. Johansson, and D. Hult, Hyperbranched aliphatic polyesters. Macromol. 28, 1698 (1995).
3. S. Svenson and D. A. Tomalia, Dendrimers in biomedical applications - Reflections on the field. Adv. Drug Del. Rev. 57, 2106 (2005).
4. A. Nakhlband, J. Barar, A. Bidmeshkipour, H. R. Heidari, and Y. Omidi, Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells. J. Biomed. Nanotechnol. 6, 360 (2010).
5. Y. Cheng, M. Li, and T. Xu, Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies. J. Phys. Chem. B 112, 8884 (2008).
6. M. F. Neerman, The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukemic drug 6-mercaptopurine. AntiCan. Drugs 18, 839 (2007).
7. A. Myc, T. B. Douce, N. Ahuja, A. Kotlyar, J. Kukowska-Latallo, T. P. Thomas, and J. P. Baker, Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Antican. Drugs 19, 43 (2008).
8. C. Kojima, K. Kono, K. Maruyama, and T. Takagishi, Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug. Chem. 11, 910 (2000).
9. D. Bhadra, S. Bhadra, S. Jain, and N. K. Jain, A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 257, 111 (2003).
10. B. Devarakonda, A. Judefeind, S. Chigurupati, S. Thomas, V. G. Shah, P. D. Otto, and M. M. De Villiers, The effect of polyamidoamine dendrimers on the in vitro cytotoxicity of paclitaxel in cultured prostate cancer (PC-3M) cells. J. Biomed. Nanotechnol. 3, 384 (2007).
11. R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N. B. McKeown, and A. D'Emanuele, The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int. J. Pharm. 25, 263 (2003).
12. R. Qi, Y. Gao, Y. Tang, R. He, T. T. Liu, Y. He, S. Sun, B. Li, Y. Li, and G. Liu, PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression. AAPS J. 11, 395 (2009).
13. M. H. Han, J. Chen, J. Wang, S. L. Chen, X. T. Wang, M. H. Han, J. Chen, J. Wang, S. L. Chen, and X. T. Wang, Blood compatibility of polyamidoamine dendrimers and erythrocyte protection. J. Biomed. Nanotechnol. 6, 82 (2010).
14. S. Bai and F. Ahsan, Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin. Pharm. Res. 26, 539 (2009).
15. F. Alexis, E. M. Pridgen, R. Langer, and O. C. Farokhzad, Nanoparticle technologies for cancer therapy. Hand. Exper. Pharm. 197, 55 (2010).
16. C. K. Nguyen and T. K. D. Hoang, Dendritic polymer based on polyester and polyamine. J. Sci. Technol. 46, 166 (2008).
17. N. Q. Tran, Y. K. Joung, E. Lih, K. M. Park, and K. D. Park, RGDconjugated in situ forming hydrogels as cell-adhesive injectable scaffolds. Macromol. Res. 19, 300 (2011).
18. J. Jansson, K. Schille, G. Olofsson, R. Cardoso, and W. Loh, The interaction between PEO-PPO-PEO triblock copolymers and ionic surfactants in aqueous solution studied using light scattering and calorimetry. J. Phys. Chem. B 108, 82 (2004).
19. J. Fu, D. Wang, T. Wang, W. Yang, Y. Deng, H. Wang, S. Jin, and N. He, High entrapment efficiency of chitosan/polylactic acid/tripolyphotspate nanosized microcapsules for rapamycin by an emulsion-evaporation approach. J. Biomed. Nanotechnol. 6, 725 (2010).
20. K. T. Papazisis, G. D. Geromichalos, K. A. Dimitriadis, and A. H. Kortsaris, Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Meth. 208, 151 (1997).
21. N. Q. Tran, Y. K. Joung, E. Lih, and K. D. Park, In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromol. 12, 2872 (2011).
22. D. H. Nguyen, J. H. Choi, Y. K. Joung, and K. D. Park, Disulfidecrosslinked heparin-pluronic nanogels as a redox-sensitive nanocarrier for intracellular protein delivery. J. Bioact. Compat. Polym. 2, 287 (2011).
23. J. Liu, Z. Qiu, S. Wang, L. Zhou, and S. Zhang, A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed. Mater. 5, 065002 (2010).
24. G. Bocci, R. Danesi, A. D. Paolo, F. Innocenti, G. Allegrini, A. Falcone, A. Melosi, M. Battistoni, G. Barsanti, P. F. Conte, and M. D. Tacca, Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients. Clin. Can. Res. 6, 3032 (2000).